Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Three key findings result from our study: (1) pwIIH treated with GLP-1-RAs lose significantly more weight than pwIIH electing for UCWM only, (2) treatment with GLP-1-RAs is associated with favorable headache outcomes, and (3) treatment with GLP-1-RAs is not associated with any severe adverse events in IIH, and thus presents a safe treatment option for weight management in pwIIH
A treatment course followed by appropriate washout can be an effective pre-conception strategy when planned with a healthcare provider
But there was one bit of reassuring news: The researchers found no increased risk of Cesarean delivery, or of babies being born with unusually high or low birth weight or abnormal birth length
Dosing, duration, monitoring, and adjustment guidelines
